<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="oil1000/PMC6590871/results/search/disease/results.xml">
  <result pre=": Microbiology : Microbial Genomics: Microbiome Puerarin prevents high-fat diet-induced" exact="obesity" post="by enriching Akkermansia muciniphila in the gut microbiota of"/>
  <result pre="microbiota plays a significant role in the pathophysiological processes of" exact="obesity" post="and its related metabolic symptoms in the host. Puerarin,"/>
  <result pre="metabolism-related problems including cardio- and cerebrovascular diseases, type 2 diabetes," exact="chronic kidney disease," post="musculoskeletal disorders, and digestive diseases [ 3, 4], therefore"/>
  <result pre="that the gut microbiota plays a crucial role in diet-related" exact="obesity" post="and glucose and/or lipid metabolism disorders [ 5, 6]."/>
  <result pre="gut microbiota isolated from donors with high-fat diet (HFD) induced" exact="obesity" post="[ 9], suggesting a causal relation between gut dysbiosis"/>
  <result pre="livers as the intestinal microbiota determines the development of non-alcoholic" exact="fatty liver disease" post="in mice [ 10, 11], whereas, steatosis is among"/>
  <result pre="as the intestinal microbiota determines the development of non-alcoholic fatty" exact="liver disease" post="in mice [ 10, 11], whereas, steatosis is among"/>
  <result pre="bacterial species Akkermansia muciniphila ( A. muciniphila) inversely correlates with" exact="obesity" post="and diabetes in both mice and humans [ 13]."/>
  <result pre="been suggested as a therapeutic target in various diseases, including" exact="obesity" post="and diabetes [ 14]. Currently, most efforts are focused"/>
  <result pre="was performed at least three times. Results Puerarin prevents HFD-induced" exact="obesity" post="in mice and provides additional benefits To assess the"/>
  <result pre="( Fig 1C and 1D). Similarly, puerarin significantly ameliorated the" exact="hyperglycemia" post="in HFD-fed mice with a significantly higher glucose disposal"/>
  <result pre="with the HFD group: #P &amp;lt; 0.05. Discussion HFD induced" exact="obesity" post="in rodents well mimicked human metabolic syndrome with increase"/>
  <result pre="0.05. Discussion HFD induced obesity in rodents well mimicked human" exact="metabolic syndrome" post="with increase body weight and steatosis, impaired glucose and"/>
  <result pre="fat tissue inflammation [ 6, 37]. Although, clinic manifestations of" exact="metabolic syndrome," post="e.g. lipid or glucose metabolic disorder dominant, were variable"/>
  <result pre="Although, clinic manifestations of metabolic syndrome, e.g. lipid or glucose" exact="metabolic disorder" post="dominant, were variable significantly, a low-grade inflammation appears to"/>
  <result pre="S1 Fig), in addition to its beneficial effects in preventing" exact="obesity" post="and the related complications, including steatosis and insulin resistance"/>
  <result pre="gut microbiota at deeper taxonomic levels that are associated with" exact="obesity" post="and the related phenotype should be considered [ 45]."/>
  <result pre="has been recently used in the treatment of diabetes and" exact="obesity" post="[ 48]. Notably, the suggested beneficial bacterial genus Faecalibacterium"/>
  <result pre="oral administration of Gegen Qinlian Decoction, which alleviated type 2" exact="diabetes mellitus" post="[ 49] was not enriched in our study. This"/>
  <result pre="P , et al. Human colonic microbiota associated with diet," exact="obesity" post="and weight loss. Int J Obesity. 2008; 32: 1720–"/>
  <result pre="AL , et al. Gut microbiota from twins discordant for" exact="obesity" post="modulate metabolism in mice. Science. 2013; 341: 1079– U1049."/>
  <result pre=", Obin MS , Zhao LP . The gut microbiota," exact="obesity" post="and insulin resistance. Mol Aspects Med. 2013; 34: 39–"/>
  <result pre="C , et al. Intestinal microbiota determines development of non-alcoholic" exact="fatty liver disease" post="in mice . Gut. 2013; 62( 12), 1787– 1794."/>
  <result pre=", et al. Intestinal microbiota determines development of non-alcoholic fatty" exact="liver disease" post="in mice . Gut. 2013; 62( 12), 1787– 1794."/>
  <result pre="Frozen vs fresh fecal microbiota transplantation and clinical resolution of" exact="diarrhea" post="in patients with recurrent Clostridium difficile infection a randomized"/>
  <result pre="Su Y , et al. Protective effect of puerarin on" exact="diabetic retinopathy" post="in rats. Mol Biol Rep. 2009; 36: 1129– 1133."/>
  <result pre="Y , et al. Protective effect of puerarin on diabetic" exact="retinopathy" post="in rats. Mol Biol Rep. 2009; 36: 1129– 1133."/>
  <result pre="al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced" exact="obesity" post=". P Natl Acad Sci USA. 2013; 110: 9066–"/>
  <result pre="extract of Pueraria lobata and its main compound, puerarin, prevent" exact="obesity" post="by increasing the energy metabolism in skeletal muscle ."/>
  <result pre="energy harvesting capacity of the gut microbiota: relationship to diet," exact="obesity" post="and time in mouse models . Gut. 2010; 59;"/>
  <result pre="S , Winer S . The intestinal immune system in" exact="obesity" post="and insulin resistance. Cell Metab. 2016; 23; 413– 426."/>
 </snippets>
</snippetsTree>
